ABBV has been in the news 450% more than usual
Apr 18, 2025, 10:31 AM
6.38%
What does ABBV do
AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
ABBV has been in the news recently: ABBVIE's relevant entities are not mentioned in the provided information. The text discusses investment opportunities and legal matters related to Global Payments, Capital One, and Cerevel Therapeutics Holdings, Inc. but does not directly relate to ABBVIE.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.